US Stocks
/
Immunovant, Inc. Share Price

Immunovant, Inc. Share Price

NASDAQ: IMVT | Mid Cap
$32.04
-$0.06 (-0.19%) Last updated on 08 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Immunovant, Inc. Stock Performance

Open
$31.82
Prev. Close
$32.10
Circuit Range
N/A
Day Range
$31.82 - $32.68
Year Range
$15.96 - $45.26
Volume
36,199
Average Traded
$32.26

Immunovant, Inc. Share Price Today

As of 8 October 2026, Immunovant, Inc.'s share price is $32.04. The stock opened at $31.82, compared to its previous close of $32.10. During today's trading session, Immunovant, Inc.'s share price traded between $31.82 and $32.68, with an average price of $32.25. Over the past 52 weeks, the stock has recorded a high of $45.26 and a low of $15.96. In terms of performance, Immunovant, Inc.'s share price has risen by 18.01% over the last six months and is up 29.80% on a year-on-year basis.

Immunovant, Inc. Share Price Chart

$31.82$32.68
L
Show Current Price
H

Immunovant, Inc. Stock Fundamentals & Key Indicators

Market Cap
$4.86B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.61
Revenue (TTM)
$0.00
Return On Equity (TTM)
-73.19%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-21.12%

Immunovant, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$126.50-$110.64-$147.86-$153.22
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A12.54%-33.64%-3.63%

Immunovant, Inc. Annual Profit & Loss

All figures in USD

Particulars2023202420252026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$210.96-$259.34-$413.84-$505.61
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-22.93%-59.57%-22.18%

About Immunovant, Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.

Immunovant, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$34.09
$31.99
-5.36%
Sep 2026
$40.52
$33.80
-22.86%
Aug 2026
$38.32
$43.81
+13.39%
Jul 2026
$38.55
$38.64
+0.23%
Jun 2026
$32.75
$38.55
+15.87%
May 2026
$27.41
$33.27
+22.54%
Apr 2026
$25.04
$27.15
+9.21%
Mar 2026
$27.11
$24.86
-10.41%
Feb 2026
$25.80
$27.75
+6.63%
Jan 2026
$25.68
$26.02
+2.42%
Dec 2025
$23.86
$25.41
+5.13%
Nov 2025
$24.64
$24.17
-2.09%

IMVT Share Price FAQs

What is Immunovant, Inc. share price today?

chevron-up
Immunovant, Inc. share price today is $32.04 as on October 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Immunovant, Inc. stock?

chevron-up
The 52 week high of Immunovant, Inc. stock is $45.26, while the 52 week low is $15.96 as of 8 Oct '26.

What is IMVT's market capitalisation today?

chevron-up
IMVT market capitalisation is $4.86B as of October 8, 2026, at 4:08 pm IST.

What is IMVT's net income for the last quarter?

chevron-up
IMVT's net income for the last quarter is -153.22B USD.

What is the 5 year returns of IMVT?

chevron-up
The 5 year returns of IMVT is 298.56% as on 8 Oct '26.

What is the high & low stock price of IMVT today?

chevron-up
IMVT stock price hit a high of $32.68 and low of $31.82 as of 8 Oct '26.

Can I buy IMVT shares in India?

chevron-up
Yes. You can buy IMVT in India by opening an international trading account.